PRODUCTS R&D
產品與研發
研發團隊

研發團隊


       精實的研究團隊於實驗室主持人張家榮博士與吳佩穎博士的帶領下，作為瑞寶基因製造優良疫苗產品的強力後盾, 使瑞寶基因成為臺灣少數兼具疫苗生產能力與研發實力的動物疫苗公司。團隊成員擁有生物技術、動物科學、獸醫等相關科系碩士學位，並具多年生物科技領域工作經驗，累積充沛研究能量，研發實力日漸雄厚。

       瑞寶基因之專利技術平台是實驗室研究的核心基礎，也是奠定瑞寶基因立足動物疫苗界的基石。同時，為加速新疫苗開發與優化現有產品製程，研究團隊努力尋求多方堅強的技術策略夥伴合作，包含財團法人農業科技研究院、農委會家畜衛生試驗所、中央研究院、國立臺灣大學、國立嘉義大學、國立中興大學、屏東科技大學、中國醫藥大學、國立交通大學、國立清華大學等，不論是技術授權或產學合作方案皆有具體的成果，展現瑞寶基因產品開發堅強實力。
 

發表文獻


1.Taehwan Oh, Hanjin Kim, Kee Hwan Park, Jiwoon Jeong, Siyeon Yang, Ikjae Kang, Su-Jin Park, and Chanhee Chae. 2019. A comparative study of the efficacy of a porcine reproductive and respiratory syndrome subunit and a modified-live virus vaccine against respiratory diseases in endemic farms. Can J Vet Res. 83(2): 110–121
2.Taehwan Oh, Hanjin Kim, Kee Hwan Park, Jiwoon Jeong, Ikjae Kang, Siyeon Yang, Chanhee Chae. 2019. Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts. Can J Vet Res. 83(4): 248–254.
3. Jiwoon Jeong , Seeun Kim , Changhoon Park , Ikjae Kang , Kee Hwan Park , Hee Jin Ham , Chanhee Chae. 2018 Effect of Vaccination With a Porcine Reproductive and Respiratory Syndrome Subunit Vaccine on Sow Reproductive Performance in Endemic Farms. Vet Rec. 26;182(21):602
4. Do Tien Duy, Hanjin Kim, Jiwoon Jeong, Kee Hwan Park, Siyeon Yang, Taehwan Oh, Seeun Kim, Ikjae Kang, and Chanhee Chae. 2018. Comparative evaluation of the efficacy of commercial and prototype PRRS subunit vaccines against an HP-PRRSV challenge. J Vet Med Sci. 80(9): 1463–1467.
5. Jiwoon Jeong, Changhoon Park, Kyuhyung Choi, and Chanhee Chae. 2017. Can J Vet Res. Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus. Can J Vet Res. 81(1): 12–21.